| Product NDC: | 13668-089 | 
| Proprietary Name: | Olanzapine | 
| Non Proprietary Name: | Olanzapine | 
| Active Ingredient(s): | 15 mg/1 & nbsp; Olanzapine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 13668-089 | 
| Labeler Name: | Torrent Pharmaceuticals Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA091415 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20111025 | 
| Package NDC: | 13668-089-90 | 
| Package Description: | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-089-90) | 
| NDC Code | 13668-089-90 | 
| Proprietary Name | Olanzapine | 
| Package Description | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-089-90) | 
| Product NDC | 13668-089 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Olanzapine | 
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING | 
| Route Name | ORAL | 
| Start Marketing Date | 20111025 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Torrent Pharmaceuticals Limited | 
| Substance Name | OLANZAPINE | 
| Strength Number | 15 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |